Timothy Richard Smith MD
Associate Professor, Neurosurgery, Harvard Medical School
Join to View Full Profile
60 Fenwood Ave.Department Of NeurosurgeryBoston, MA 02115
Phone+1 617-525-3060
Fax+1 312-695-0225
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Neurological Surgery, 2008 - 2014- McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 2007 - 2008
David Geffen School of Medicine at UCLAClass of 2007
Certifications & Licensure
ME State Medical License Current
MA State Medical License 2014 - 2027
CA State Medical License 2024 - 2026
RI State Medical License 2023 - 2026
CT State Medical License 2023 - 2025
NH State Medical License 2019 - 2025
VT State Medical License 2023 - 2024
American Board of Neurological Surgery Neurological Surgery- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHyperprogression of brain metastases following initiation of immune checkpoint inhibitors.Charissa A C Jessurun, Francesca Siddi, Noah L A Nawabi, Alexander F C Hulsbergen, Yu Tung Lo
Journal of Neuro-Oncology. 2025-05-01 - The utility of the 5-Item frailty index in assessing the risk of complications and mortality following surgical management of non-traumatic subarachnoid hemorrhage.Qais AbuHasan, Jakob V E Gerstl, Chady Omara, Harshit Arora, Muhieddine Labban
Journal of Clinical Neuroscience. 2025-04-01 - SAFETY OF NON-OSSEOUS UNION OF TYPE II ODONTOID FRACTURES - A MULTI-INSTITUTIONAL COHORT STUDY.Chady Omara, Anna B Lebouille-Veldman, Alexander G Yearley, Azra Gül, James Withers
The Spine Journal. 2025-03-26
Press Mentions
First-Line Treatment with Checkpoint Inhibitors Associated with Improved Overall Survival for Patients with Melanoma Brain MetastasesJuly 12th, 2018
RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for Its Regenerative Bone Adhesive for Cranial Flap FixationDecember 14th, 2023- FDA Greenlights RevBio’s Innovative Bone Glue Trial for Cranial SurgeryDecember 23rd, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
